Neuropathology of COVID-19 brains
Although primarily targeting the respiratory system, coronavirus disease 2019 (COVID-19) also manifests with central nervous system (CNS)-related symptoms in up to 80% of the patients. Little is known not only about SARS-CoV-2 neuropathology, but also about the clinical course of pre-existing CNS autoimmune disease and concurrent SARS-CoV-2-infection. Multiple sclerosis (MS) is the most frequent